Provided by Tiger Trade Technology Pte. Ltd.

Mersana Therapeutics Inc.

29.08
0.0000
Volume:- -
Turnover:20.77M
Market Cap:145.36M
PE:-2.06
High:29.08
Open:29.08
Low:29.08
Close:29.08
52wk High:36.25
52wk Low:5.21
Shares:5.00M
Float Shares:3.75M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0861
EPS(LYR):-14.1163
ROE:-505.14%
ROA:-36.27%
PB:-2.44
PE(LYR):-2.06

Loading ...

Mersana Therapeutics Shareholders to Receive $25 Per Share in Acquisition by Day One Biopharmaceuticals

Reuters
·
Jan 06

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:05 AM

Reuters
·
Jan 06

Day One Completes Acquisition of Mersana Therapeutics

GlobeNewswire
·
Jan 06

NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM

Reuters
·
Jan 06

Serina Therapeutics Appoints Dr. Joshua Thomas as Vice President and Head of Chemistry

Reuters
·
Dec 12, 2025

Mersana Therapeutics Q3 EPS USD -1.51

Reuters
·
Nov 20, 2025

Mersana Therapeutics Faces High Stakes with Potential Day One Biopharmaceuticals Merger Delays

TIPRANKS
·
Nov 15, 2025

BUZZ-Nasdaq biotech index hits record high, set to gain nearly 5% this week

Reuters
·
Nov 15, 2025

Mersana Therapeutics reports third quarter 2025 financial results

Reuters
·
Nov 14, 2025

BRIEF-Mersana Therapeutics Q3 EPS USD -1.51

Reuters
·
Nov 14, 2025

Mersana Therapeutics Q3 Collaboration Revenue USD 11.009 Million

THOMSON REUTERS
·
Nov 14, 2025

U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66

Reuters
·
Nov 14, 2025

Mersana Therapeutics Inc : William Blair Cuts to Market Perform Rating

THOMSON REUTERS
·
Nov 14, 2025

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires Live
·
Nov 14, 2025

William Blair downgrades Mersana Therapeutics (MRSN) to a Hold

TIPRANKS
·
Nov 14, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA

Reuters
·
Nov 14, 2025

Mersana Therapeutics Inc : Baird Raises Target Price to $29 From $8

THOMSON REUTERS
·
Nov 14, 2025

Mersana Therapeutics Inc : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $29 From $44

THOMSON REUTERS
·
Nov 13, 2025

Mersana Therapeutics Inc : Truist Securities Cuts to Hold From Buy; Cuts Target Price to $30.75 From $36

THOMSON REUTERS
·
Nov 13, 2025

Oppenheimer says Day One paying up to $285M for Mersana ‘is interesting’

TIPRANKS
·
Nov 13, 2025